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Abstract
Background: Despite high cardiovascular mortality in Central Asian republics of the former Soviet Union, there is
limited information about major risk factors, including blood lipids. We investigated the prevalence of impaired
concentrations of blood lipids, the awareness, treatment and control of hypercholesterolemia, and factors associated
with these indicators in urban and rural populations in Kazakhstan.
Methods: We conducted a cross-sectional study of random urban and rural population samples (the state capital Astana
and Akmol village). Men and women aged 50–74 years were examined; a total of 954 adults participated (response rate
59%). Serum concentrations of total, LDL and HDL cholesterol and triglycerides and a range of other cardiovascular risk
factors were measured.
Results: The overall prevalence of hypercholesterolemia (total cholesterol ≥6.2 mmol/l) was 37%; among subjects with
hypercholesterolemia, 57% were aware of their condition, 41% took medication and 23% had total cholesterol
<6.2 mmol/l (4.5% <5 mmol/l). The prevalence, awareness, treatment, and control of hypercholesterolemia were all
higher in the urban than the rural area. Similarly, the proportions of subjects with impaired concentrations of specific
lipids fractions were also considerably higher in the urban population. Most associations with other covariates were in
the expected direction.
Conclusions: This study found relatively high prevalence of dyslipidemia in the Kazakh population, and the blood lipid
profile was less favourable in the urban area. These pronounced urban–rural differences may be related to urbanization,
the associated nutrition transition and to access to health care.
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Background
Dyslipidemia is an important modifiable risk factor for
cardiovascular disease (CVD); based on WHO global esti-
mates, dyslipidemias cause one third of ischemic heart
disease and one fifth of global cerebrovascular disease,
and equates to nearly 2.6 million deaths every year
worldwide [1]. Various lipid abnormalities, such as in-
creased total and low-density lipoprotein cholesterol, low
concentrations of high-density lipoprotein cholesterol and
high triglycerides concentrations, and their combinations,
have been implicated as potential independent predictors
of CVD [2–4].
According to WHO, the age-standardized prevalence of
raised total cholesterol (≥6.2 mmol/l) in Kazakhstan was
estimated as 12%, which is similar to Russian Federation
(15%) but considerably higher than in other Central Asian
countries. The highest estimate is for Turkmenistan with
8% and the lowest in Tajikistan with 5%, although estimates
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in Central Asian countries are much lower than developed
countries (e.g. 25% in Germany and 22% in Great Britain).
[5] Unfortunately, as there have been no representative
individual-level studies on dyslipidemia in the Central
Asian region, it is hard to reliably assess the magnitude of
the problem. Given the rapid societal and economic
changes after the breakup of the former Soviet Union and
the associated increase in CVD mortality rates, assessment
of dyslipidemias and other cardio-metabolic factors in the
Central Asian republics is an urgent public health matter.
The traditional Kazakh diet included high consumption
energy-dense food (particularly saturated fat) but it was it
was combined with high physical activity. By contrast, the
post-Soviet transition period has been characterised by
rapid westernisation and urbanisation, leading to an in-
crease in food availability, including an increasing density
of food and wine stores, in this formerly isolated society.
This resulted in changing patterns of food consumption at
the time of declining physical activity [6, 7].
The aim of the present study was to investigate the
mean levels and prevalence of impaired concentrations
of serum lipids, and to present estimates of prevalence,
awareness, treatment, and control levels of hypercholes-
terolemia in general population samples in an urban area
(Astana, the capital city) and an adjacent rural area
(Akmol village) in Kazakhstan.
Methods
Study population
This cross-sectional study was implemented in the Astana
region between November 2012 and March 2015. The
urban area was Astana city, the capital of Kazakhstan, and
the rural population was the Akmol village. Astana, the
capital of Kazakhstan, is important because it sets the
trend for the rest of the country. It is likely that the
current situation of Astana is the future of other urban
settings in Kazakhstan and other Central Asian cities. The
rural population around Astana is large and consists of
several villages. The Akmol village, located approximately
50 km from Astana city, was selected because it is suffi-
ciently far from Astana city to preserve its rural nature
while it is still close enough to allow regular transport of
biological samples. The participants were randomly se-
lected (stratified by sex and 5-year age groups) from the
lists of all residents in the age range 50–74 years who were
registered at local outpatient clinics (polyclinics). The
recruiting procedures included invitation to a polyclinic
by landline phone calls; if telephone communication was
not successful, participants were visited at their home and
invited to participate in the study. A total of 954 of adults
aged 50–74 years were recruited (480 in Astana city and
474 in Akmol). The overall response rate was 59% (56% in
urban and 63% in rural area).
Data were collected by trained doctors using a stan-
dardized survey protocol and paper questionnaires; the
data were subsequently entered into a database. The
structured questionnaire included an overall assessment
of the patient’s health, medical history, lifestyle and
socio-economic indicators. The examination included
blood pressure measurement, anthropometric measures
(height, weight, waist and hip circumference) and collec-
tion of a venous blood sample.
Measurements
According to the previously published analyses on diabetes
and arterial hypertension [8, 9] the subjects were invited to
visit the polyclinic early in the morning after an overnight
fast. The fasting status was self-reported by participants and
recorded in the questionnaire. Those who did not meet the
fasting status requirements (fasting for at least 12 h prior to
examination) were invited to visit the polyclinic on another
occasion. In both Astana city and Akmol village, all blood
samples were collected in EDTA vacutainer. Vacutainers
were carefully shaken, and then centrifuged. Cooled serum
samples were transferred to Astana city, and serum total
cholesterol (TC), low-density lipoprotein cholesterol (LDL-
C), high-density lipoprotein cholesterol (HDL-C), triglycer-
ides (TG) and glucose concentration were measured by
automatic modular analyzer Cobas 8000, Roche Diagnostics
(Germany) using the following reagents for the assays
(reagent catalog number: 05168538190 (TC), 05171369190
(LDL-C), 05168805190 (HDL-C), 05171407190 (TG)). The
maximum delay time for this biochemical analysis was 4 h
after blood collection.
Hypercholesterolemia and abnormal lipid concentrations
To study prevalence, awareness, treatment and control of
hypercholesterolemia, we used two conventional cut-offs
of TC concentrations. First, the primary definition of
hypercholesterolemia was set as total serum cholesterol
≥6.2 mmol/l (240 mg/dl) and/or current use of cholesterol
lowering medication. [10] Secondly, for comparisons with
other studies, we used another cut-off point for hyperchol-
esterolemia total cholesterol ≥5.0 mmol/l and/or current
use of cholesterol lowering medication. [11] Awareness
status was assessed by the question whether the subject
had been told by a doctor that they had high level of chol-
esterol lipids. Because the vast majority of the general
public do not know about specific lipid fractions, we asked
about total cholesterol levels in this question, similar to
many other studies, e.g. the WHO MONICA Project. [12]
Subjects who reported taking regular cholesterol lowering
medications were considered to be on treatment for high
cholesterol. Control of hypercholesterolemia among those
with high cholesterol was defined as fasting serum total
cholesterol less than 6.2 mmol/l (or 5.0 mmol/l in second-
ary analyses).
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For other lipids, we used the cut-offs recommended by
the National Cholesterol Education Program Expert Panel
on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (ATP III): raised level of low-density
lipoprotein cholesterol ≥4.15 mmol/l (160 mg/dl), raised
serum triglycerides levels ≥2.26 mmol/l (200 mg/dl) and
low level of high-density lipoprotein cholesterol was set as
<1.04 mmol/l (40 mg/dl) for men and for women. [10].
Obesity
We used two indices of obesity: body mass index (BMI,
kg/m2) and waist to hip ratio (WHR) to assess overall
and central obesity, respectively. Weight of subjects with
light clothing was measured by standard balanced scales
to the nearest 0.1 kg, and height was measured by a steel
stadiometer to the nearest 0.1 cm. As recommended by
WHO, BMI was classified as normal (BMI 18.5–24.9),
overweight (BMI 25–29.9) and obese (BMI over 30 kg/m2).
Waist and hip circumferences were measured using a
standard tape measure. The waist circumference was
measured halfway between the costal margin and iliac
crest, and hip circumference was measured at the widest
portion of the buttocks. WHR was categorized into two
groups based on WHO cut-off points: central obesity
was defined as a waist to hip ratio above 0.90 for men
and above 0.85 for women. [13].
Diabetes
The diabetes was classified as fasting plasma glucose
(FPG) concentration more than or equal to 7.0 mmol/l
(126 mg/dl) or self-reported diabetes medication use; the
questionnaire did not specify the type of diabetes (I or II).
The measurements and derived indices were described in
detail previously [9].
Arterial hypertension
Before blood pressure measurement participants were
asked to sit calmly for 5 min. Blood pressure was mea-
sured by OMRON M6 comfort with three consecutive
readings on the right arm in sitting position, with a two-
minute interval between measurements. Hypertension
was defined as SBP ≥140 mmHg and/or DBP ≥90 mmHg,
and/or the use of antihypertensive medication in the last
2 weeks. More details about the procedures of blood
pressure measurements were reported elsewhere.[8].
Socio-demographic and behaviour characteristics
The socio-demographic and behaviour characteristics, as
previously reported [8, 9] included age, sex and urban
vs. rural area of residence and several socioeconomic
and demographic variables. Marital status was classified
as married or unmarried (widowed, divorced and single)
and education was divided into primary or less, vocational/
secondary, and university. The ethnicity was classified as
Kazakh, Russian and other. Car ownership (yes vs. no)
and material deprivation were used as markers of the
economic status. Material deprivation was assessed by
three questions (how often participants do not have
enough money for food, clothes and paying bills for their
households), and participants were classified into three
categories (high, intermediate and low). Smoking status
was evaluated using two questions: if subject currently
smokes, and if not, did he/her smoke in the past, and ac-
cordingly individuals were categorized as current smokers,
ex-smokers, or non-smokers.
Statistical analysis
In descriptive tables we present unadjusted frequencies
of all predictor and outcome variables by urban or rural
residence. The association between outcomes and covar-
iates (socio-demographic characteristics, BMI, WHR, be-
haviours, hypertension and diabetes) was estimated
using logistic regression adjusted for age and sex. To es-
timate independent effects of each covariate on the
prevalence of hypercholesterolemia, a multivariable
model was built with all covariates entered in the logistic
regression model. As the numbers of subjects in models
analysing awareness, treatment and control of hyper-
cholesterolemia were too small for meaningful multivari-
able analyses, only age-sex adjusted estimates are
reported for these outcomes. For supplementary tables,
we also estimated the age-sex-adjusted means of all
serum lipids by all covariates, using linear regression. To
account for intra-cluster correlation (within each area),
we initially used the “cluster” option in STATA; however,
since this approach yielded very small standard errors
(possibly due to negative intra-cluster correlation), we
used robust regression (option “robust” in STATA)
which provided more conservative estimates. All ana-
lyses were performed using STATA software, version 12
(College Station, Texas, USA).
Results
Table 1 shows descriptive characteristics of the urban
and rural population samples in the Astana region in
Kazakhstan. The mean age of the participants was al-
most similar between the urban and rural regions.
Among cardiometabolic factors, 13% of subjects had dia-
betes, 72% had hypertension and 44% were obese (there
were no underweight individuals in the study), and 72%
had central obesity. BMI, waist-hip ratio, diabetes and
fasting serum lipids, except HDL-C were higher in urban
than rural area. The percentage of smokers, higher edu-
cation and car ownership were also higher in urban than
rural area.
Table 2 presents the prevalence, awareness, treatment
and control of hypercholesterolemia. In the total sam-
ple of 954 subjects, 37.2% were classified as having
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hypercholesterolemia; the proportion of subjects with
hypercholesterolemia was almost twice as high in the urban
compared to rural area. Among subjects with hypercholes-
terolemia, 56.6% were aware of their condition, 40.6%
took medication, and 23.4% had total cholesterol con-
centrations <6.2 mmol/l. Among those aware of the
condition, 70.7% were taking medication, and among
those taking medication, 57.6% had concentrations
Table 1 Descriptive characteristics of the study population in Astana region, Kazakhstan
Variable name Astana city (urban) Akmol village (rural) Both
Total number of participants N = 480 N = 474 N = 954
Sex, (%)
Males 45.8% 41.4% 43.6%
Females 54.2% 58.7% 56.4%
Age mean, (SD) 61.2 (7.3) 60.3 (7.3) 60.7 (7.3)
Total cholesterol (mmol/l), mean (SD) 5.89 (1.51) 5.44 (1.09) 5.67 (1.34)
LDL-C (mmol/l), mean (SD) 3.71 (0.97) 3.52 (0.96) 3.62 (0.97)
HDL-C (mmol/l), mean (SD) 1.30 (0.36) 1.46 (0.40) 1.38 (0.39)
TG (mmol/l), mean (SD) 1.66 (1.08) 1.52 (1.04) 1.59 (1.06)
Diabetes prevalence, (%) 16.3% 8.7% 12.5%
Arterial Hypertension prevalence, (%) 70.3% 74.1% 72.2%
BMI, mean (SD) 29.8 (4.9) 29.2 (5.3) 29.5 (5.1)
BMI categories, (%)
18.50 - 24.99 (normal) 13.4% 20.3% 16.8%
25.00 - 29.99 (pre-obese) 40.6% 37.9% 39.3%
Over 30 (obese) 46.0% 41.7% 43.9%
Waist–hip ratio, (%)
≥0.9 in men and ≥0.85 in women
81.7% 61.7% 71.7%
Smoking status
Current smoker 17.4% 13.9% 15.6%
Ex-smoker 21.6% 16.5% 19.0%
Non-smoker 61.0% 69.7% 65.3%
Marital status, (%)
Married 73.1% 73.7% 73.4%
Unmarried 26.9% 26.3% 26.6%
Education, (%)
1 Primary 36.3% 39.2% 37.7%
2 Secondary 21.3% 45.3% 33.2%
3 Higher 42.5% 15.5% 29.2%
Car ownership, (%)
No 38.8% 50.9% 44.8%
Yes 61.2% 49.1% 55.2%
Ethnicity, (%)
Kazakhs 57.5% 58.4% 58.0%
Russians 26.0% 27.2% 26.6%
Others 16.5% 14.4% 15.4%
Deprivation level, (%)
high level of deprivation 26.9% 26.2% 26.6%
Intermediate level of deprivation 29.4% 33.8% 31.6%
low level of deprivation 43.6% 40.0% 41.8%
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<6.2 mmol/l. There were pronounced differences between
urban and rural areas. The prevalence of awareness, treat-
ment and control of hypercholesterolemia were about 1.5
times higher in the urban vs. rural area. Prevalence, aware-
ness and treatment were about 1.5 times higher in women
than men in both urban and rural areas, although control
was better among men than women in both areas.
The prevalence, awareness, treatment and control of
hypercholesterolemia using the lower cut-off of
≥5.0 mmol/l are shown in Additional file 1: Table S1.
Using this lower cut-off, the overall prevalence of hyper-
cholesterolemia was 72.8%. There is consistent distribu-
tion of all characteristics, with higher levels in urban
area. However, the gap between urban and rural areas
increased considerably; the prevalence of awareness and
treatment of hypercholesterolemia were more than two
times higher in urban area. Successful control of hyper-
cholesterolemia in the rural area was 1.3% compared
with 7% in Astana city; among those aware of having
hypercholesterolemia, the proportions with successful
control was 10.3 and 25.7%, respectively. Differences be-
tween men and women were similar to those presented
for the standard hypercholesterolemia (≥6.2 mmol/l).
Age and sex standardized means of serum lipids
and respective age and sex adjusted odds ratios for
impaired lipid concentrations by covariates are shown in
Additional file 2: Table S2. Impaired lipid concentrations
were more common in women, those who were obese and
in subjects with diabetes and hypertension. The odds of
dyslipidemia in the rural area was about half of that in
Astana city. Car ownership, deprivation levels and educa-
tion were statistically significantly associated with dyslipid-
emia prevalence. Russian ethnicity was associated with
high rates of impaired lipid concentrations.
Table 3 shows the odds ratios of hypercholesterolemia
prevalence, awareness, treatment and control by cova-
riates. In age-adjusted model, the prevalence of hyper-
cholesterolemia was associated with being female, higher
age, obesity and central obesity, diabetes and hyper-
tension. The odds of prevalence, awareness, treatment
and control were also substantially lower in the rural vs.
urban area. Among the socio-demographic measures,
deprivation levels and education were statistically sig-
nificantly associated with (increased) hypercholestero-
lemia prevalence, awareness and control. As mentioned
earlier, Russian ethnicity had increased prevalence of
Table 2 Prevalence, awareness, treatment and control of hypercholesterolemia (HC) in Astana region, Kazakhstan (total cholesterol
≥6.2 mmol/l)
Men (n = 416) Women (n = 538) Both sexes (n = 954)
Prevalence 95% CI Cases/All Prevalence 95% CI Cases/All Prevalence 95% CI Cases/All
Combined Astana city and Akmol village
Prevalence of HC among all 28.4% 24.0–32.7 118/416 44.1% 39.8–48.3 237/538 37.2% 34.1–40.3 355/954
Awareness among all cases of HC 47.5% 38.3–56.6 56/118 61.2% 54.9–67.4 145/237 56.6% 51.4–61.8 201/355
Treatment among all cases of HC 33.1% 24.4–41.7 39/118 44.3% 37.9–50.7 105/237 40.6% 35.4–45.7 144/355
Treatment among aware 67.9% 55.2–80.5 38/56 71.7% 64.3–79.1 104/145 70.7% 64.3–77.0 142/201
Control among all cases of HC 26.3% 18.2–34.3 31/118 21.9% 16.6–27.2 52/237 23.4% 19.0–27.8 83/355
Control among treated 79.5% 66.2–92.7 31/39 49.5% 39.8–59.2 52/105 57.6% 49.5–65.8 83/144
Astana city (urban, n = 480)
Prevalence of HC among all 38.2% 31.7–44.7 84/220 57.3% 51.3–63.4 149/260 48.5% 44.1–53.0 233/480
Awareness among all cases of HC 56.0% 45.1–66.8 47/84 72.5% 65.2–79.7 108/149 66.5% 60.4–72.6 155/233
Treatment among all cases of HC 36.9% 26.4–47.4 31/84 49.7% 41.5–57.8 74/149 45.1% 38.6–51.5 105/233
Treatment among aware 63.8% 49.6–78.1 30/47 68.5% 59.6–77.4 74/108 67.1% 59.6–74.6 104/155
Control among all cases of HC 29.8% 19.8–39.7 25/84 24.8% 17.8–31.9 37/149 26.6% 20.9–32.3 62/233
Control among treated 80.7% 65.9–95.4 25/31 50.0% 38.3–61.7 37/74 59.1% 49.5–68.6 62/105
Akmol village (rural, n = 474)
Prevalence of HC among all 17.4% 12.0–22.7 34/196 31.7% 26.2–37.2 88/278 25.7% 21.8–29.7 122/474
Awareness among all cases of HC 26.5% 10.8–42.1 9/34 42.1% 31.5–52.6 37/88 37.7% 29.0–46.4 46/122
Treatment among all cases of HC 23.5% 8.5–38.6 8/34 35.2% 25.0–45.4 31/88 32.0% 23.6–40.4 39/122
Treatment among aware 88.9% 63.3–114.5 8/9 81.1% 67.8–94.3 30/37 82.6% 71.2–94.0 38/46
Control among all cases of HC 17.7% 4.1–31.1 6/34 17.1% 9.0–25.1 15/88 17.2% 10.4–24.0 21/122
Control among treated 75.0% 36.3–113.7 6/8 48.4% 29.8–67.0 15/31 53.9% 37.5–70.2 21/39
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Table 3 Association of selected factors with the prevalence, awareness, treatment and control of HC (≥6.2 mmol/l) in in Astana
region, Kazakhstan, OR (95% CI)
Prevalencea
OR (95% CI)
Prevalenceb
OR (95% CI)
Awarenessa,c
OR (95% CI)
Treatmenta,c
OR (95% CI)
Controlac
OR (95% CI)
Sex
Males 1 1 1 1 1
Females 1.98 (1.50–2.60) 2.54 (1.63–3.96) 1.75 (1.11–2.74) 1.60 (1.00–2.55) 0.78 (0.47–1.31)
Age groups (years)
50-54 1 1 1 1 1
55-59 1.55 (1.06–2.26) 1.63 (1.07–2.49) 1.32 (0.72–2.43) 1.48 (0.79–2.77) 0.98 (0.47–2.04)
60-64 1.44 (0.97–2.14) 1.28 (0.83–1.99) 1.20 (0.64–2.28) 1.55 (0.81–2.98) 1.25 (0.59–2.65)
65-69 1.32 (0.86–2.05) 1.20 (0.74–1.95) 1.45 (0.71–2.95) 1.29 (0.62–2.65) 1.47 (0.66–3.28)
70-75 1.44 (0.93–2.24) 1.01 (0.61–1.70) 1.16 (0.57–2.35) 1.24 (0.60–2.56) 1.23 (0.54–2.82)
Urban/Rural
Astana (urban) 1 1 1 1 1
Akmol (rural) 0.34 (0.26–0.45) 0.37 (0.26–0.51) 0.27 (0.17–0.43) 0.53 (0.33–0.85) 0.59 (0.34–1.03)
BMI (kg/m2)
18.5-24.9 1 1 1 1 1
25-29.9 1.48 (0.98–2.24) 1.00 (0.62–1.61) 1.02 (0.51–2.06) 0.62 (0.31–1.27) 0.94 (0.41–2.14)
≥ 30 1.77 (1.18–2.66) 1.12 (0.68–1.82) 1.68 (0.85–3.31) 0.91 (0.46–1.79) 1.08 (0.49–2.40)
WHR, obesity
No 1 1 1 1 1
Yes 2.12 (1.53–2.92) 1.55 (1.06–2.27) 1.30 (0.76–2.22) 1.27 (0.73–2.19) 0.69 (0.37–1.27)
Diabetes
No 1 1 1 1 1
Yes 1.71 (1.15–2.54) 1.25 (0.81–1.94) 2.29 (1.22–4.27) 1.83 (1.02–3.26) 2.00 (1.08–3.72)
Smoking
Current Smoker 1 1 1 1 1
Ex-smoker 1.05 (0.65–1.69) 0.98 (0.58–1.65) 2.28 (1.02–5.11) 1.70 (0.74–3.90) 1.01 (0.40–2.53)
Non-smoker 0.74 (0.46–1.17) 0.83 (0.50–1.39) 1.25 (0.60–2.63) 1.10 (0.51–2.37) 1.29 (0.54–3.07)
Hypertension
No 1 1 1 1 1
Yes 1.44 (1.05–1.97) 1.50 (1.05–2.13) 1.28 (0.77–2.15) 1.35 (0.79–2.29) 1.52 (0.80–2.91)
Marital status
Unmarried 1 1 1 1 1
Married 0.89 (0.64–1.22) 0.85 (0.59–1.24) 0.98 (0.59–1.63) 1.07 (0.65–1.77) 1.82 (0.97–3.39)
Education
Primary 1 1 1 1 1
Vocational 0.81 (0.58–1.12) 0.97 (0.67–1.39) 0.92 (0.54–1.56) 1.13 (0.66–1.95) 1.14 (0.62–2.12)
Higher 1.37 (0.98–1.90) 1.06 (0.73–1.53) 1.95 (1.15–3.33) 1.65 (0.98–2.78) 1.10 (0.60–2.00)
Ethnicity
Kazakh 1 1 1 1 1
Russian 1.39 (1.01–1.90) 1.33 (0.93–1.90) 0.80 (0.49–1.32) 1.05 (0.64–1.73) 0.95 (0.54–1.68)
Other 1.44 (0.99–2.11) 1.36 (0.90–2.07) 0.76 (0.42–1.37) 1.09 (0.60–1.98) 0.72 (0.35–1.50)
Car ownership
No 1 1 1 1 1
Yes 1.22 (0.92-1.62) 1.06 (0.77-1.46) 1.25 (0.79-1.98) 0.87 (0.55-1.37) 0.84 (0.49-1.44)
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hypercholesterolemia. Multivariable analysis of hypercho-
lesterolemia prevalence (Table 3, column 3) largely con-
firmed these findings, except that the association with
BMI, central obesity and diabetes were reduced, mainly
because these variables were strongly mutually correlated.
Discussion
In this population-based study in the Astana region of
Kazakhstan, we found an overall prevalence of hyper-
cholesterolemia of 37.2% using the ≥6.2 mmol/l cut-off
and 72.8% using the 5 mmol/l cut-off. There were large
differences between urban and rural settings, with
almost all lipid indicators being less favourable among
urban residents. Most associations of hypercholesterol-
emia with covariates were in the expected direction;
although we were surprised to find higher prevalence of
lipid abnormalities among ethnic Russians and among
more affluent groups.
Our study has several limitations. Firstly, the cross-
sectional study design cannot establish the direction of
some associations. Education is generally completed in
early life and is unlikely to be modified by health out-
comes, but we are less sure about deprivation, car owner-
ship and health behaviours. Second, the response rate of
the study was modest, however a response rate of 60% is
similar to many contemporary studies in Europe and else-
where [14], but as responders in epidemiological studies
have higher socio-economic status and better health than
non-responders [15] we also cannot discount the possibil-
ity that a study based in out-patient department (poly-
clinic) may have attracted less healthy and more aware
population to participate in this screening project. There-
fore, the moderate response rates may lead to both under-
and overestimation of dyslipidemia prevalence. The
response rates were slightly higher in Akmol area, but the
difference was not sufficient to introduce selection bias.
Third, adjustment for potential confounders may be
incomplete; in particularly, urban and rural areas may
differ in many aspects potentially associated with blood
lipids, and we were unable to adjust for all of these fac-
tors (e.g. nutrition).
The rural and urban areas in this study were intentionally
selected to assess urban–rural differences. Astana is a very
young capital city with a high proportion of civil servants
and more affluent and relatively better-educated popula-
tion. Akmol is a rural area proximal to Astana but it is re-
mote enough to have a stable population with low level of
migration. Nevertheless, it is likely that more distant areas,
or other regions in Kazakhstan, would present even larger
differences in socio-demographic and health indicators
compared to Astana city. The urban–rural differences in
dyslipidemias are consistent with distribution of other vari-
ables, such as obesity or diabetes. The validity of our find-
ings is supported by the fact that being female, higher BMI
and WHR, diabetes and hypertension were also positively
significantly associated with dyslipidemia, similarly to other
published studies. [16, 17].
Our literature review did not identify any previously
published studies on the awareness, treatment and con-
trol of hypercholesterolemia or determinants of any
other lipid abnormalities in Kazakhstan and other
Central Asian countries. Despite the strong association
of dyslipidemia with cardiovascular risk, with a few
exceptions [18] there is a striking lack of studies of this
important aspect of cardiovascular health in the Central
Asian region. The available information is largely limited
to WHO reports on cardiovascular disease risk factors,
with the source of the data for this region sometimes
uncertain and or being based on extrapolations from
other regions. [19, 20].
The overall high levels of awareness, treatment and
control in this study could be attributed to wealthier and
better educated population in Astana city. The high
prevalence of lipid abnormalities, as well as high levels
of dyslipidemias, diabetes and obesity in Astana city may
point towards large-scale globalization and urbanization
processes, with the associated the nutrition transition
with easy access to fast food industry and sedentary life-
style. This is consistent with reported findings from
other developing Asian populations with higher rates of
various health outcomes of non-communicable diseases
in urban compared to rural areas. [21].
Studies in low and middle-income countries frequently
reported high prevalence of dyslipidemia in urban areas
and low prevalence of awareness, treatment and control
levels in rural settings. [22, 23] We found large disparities
in hypercholesterolemia prevalence between the two loca-
tions. All hypercholesterolemia indices were lower in
Table 3 Association of selected factors with the prevalence, awareness, treatment and control of HC (≥6.2 mmol/l) in in Astana
region, Kazakhstan, OR (95% CI) (Continued)
Deprivation
High level 1 1 1 1 1
Intermediate 1.35 (0.94–1.94) 1.68 (1.12–2.52) 1.20 (0.67–2.14) 1.36 (0.75–2.44) 1.97 (0.95–4.11)
Low level 1.50 (1.07–2.11) 1.73 (1.18–2.54) 1.20 (0.69–2.07) 1.14 (0.65–1.99) 1.80 (0.89–3.63)
aage and sex adjusted, bfully adjusted for all variables in the table; cAmong those with hypercholesterolemia
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Akmol village than in Astana. However, using lower TC
cut-off point (≥5.0 mmol/l) revealed an even more marked
difference between urban and rural populations regarding
awareness and treatment of disease, and an extremely low
proportion of controlled cases of hypercholesterolemia in
the rural area.
Several recent studies have examined the distribution of
dyslipidemia. In China, the prevalence of dyslipidemias
was much lower compared to our study (12% had TC
≥6.2 mmol/l, 18% had high LDL-C, 12% had low HDL-C
and 15% had high TG); similarly, the levels of awareness,
treatment and control indices (22, 10 and 4% respectively)
were much lower. On the other hand, the Chinese study
population included younger subjects (18–79 years). [24]
A Turkish study of 20–83 year olds showed much higher
prevalence of dyslipidemias (43% had TC ≥5.0 mmol/l,
42% had low HDL-C, 36% had high LDL-C, and 36% had
high TG). [25] Compared to similar aged population
groups, our results were similar to Italy with 78.2% of sub-
jects with hypercholesterolemia (≥5.0 mmol/l). [26] Inter-
nationally, lipid abnormalities tend to be more common
in more affluent countries, [27] and this pattern may be
analogous to our finding of higher prevalence of dyslipid-
emia in the urban vs. rural populations.
Our findings confirm the association of lipid abnormal-
ities with the cardiometabolic risk factors, obesity, diabetes
and hypertension [28]. Behavioural differences, including
smoking, were also reported to be associated with hyper-
cholesterolemia and other dyslipidemias. [29, 30] We
found only small differences in abnormal lipid prevalence
by education and car ownership, and deprivation levels
were inversely associated with increased odds of dyslipide-
mias. The higher prevalence of dyslipidemia in ethnic
Russians in Kazakhstan in this study may reflect differences
in lifestyle and particularly in nutrition [31]; however, in
absence of reliable individual-level data on nutrition this is
only a speculation.
Conclusions
This study found relatively high prevalence of dyslipid-
emia in the Kazakhstan population, and the lipid pro-
file was much less favourable in the urban area, while
awareness and treatment of dyslipidemia was less com-
mon in rural areas and persons with lower education.
Providing such estimates is a necessary first step in ad-
dressing the problem. The pronounced urban vs. rural
differences raise questions about both the potential distal
and proximal causes of dyslipidemias in this middle-
income setting which should be addressed by future
research. The results suggest that health services access
and appropriate interventions should be improved in
rural areas and for persons with lower socioeconomic
status.
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